GlycoMimetics (GLYC) Tops Q2 EPS by 5c

GlycoMimetics (NASDAQ: GLYC) reported Q2 EPS of ($0.13), $0.05 better than the analyst estimate of ($0.18).

For earnings history and earnings-related data on GlycoMimetics (GLYC) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Aspire Biopharma to acquire automotive supplier for $30 million
• Adobe Systems (ADBE) Tops Q2 EPS by 14c, Offers Guidance